Francis L’Esperance, MD


Contributed by Lawrence A. Yannuzzi, MD

Fran L'Esperance with distinguished colleagues and friends. [L to R] JA Federman, Harvey Lincoff, Sandy Brucker, Kurt Gitter,  Fran L'Esperance, Larry Yannuzzi, Jack Dodick. Photo Courtesy Larry Yannuzzi, MD.

Francis Anthony L’Esperance, MD, also known as “Franny” or “Fran” combined a natural intellect with his passion for photobiologic science to be one of the most important physicians in the retinal community of my generation.

The son of Francis Anthony L’Esperance, MD, known also as Junior, he had a coveted and prestigious academic background. Beginning as an honored graduate of Deerfield Academy in 1949, he matriculated to Dartmouth College, where he graduated magna cum laude in 1953. His leadership and scholarly accomplishments were recognized by his fellow students who elected him president of the senior class. He went on to Harvard Medical School where he graduated in 1956 and earned a position as a resident at Columbia University in ophthalmology. His residency was embellished with a fellowship at the Massachusetts Eye and Ear Infirmary.

Fran always had an interest in terrestrial geography, and beyond that, in astronomy where he was fascinated by light. Not surprisingly, he pioneered the use of ophthalmic lasers and authored over 100 clinical-scientific publications and a dozen medical textbooks. He also earned twenty-three patents in bioengineering, all based on his dedicated concentration throughout his career.

Well-known as the first person to use the Excimer Laser on humans, he founded Taunton Technologies in 1986, which eventually joined its rival, Visex, in 1990. A perennial leader, he served as president of the American Board of Laser Surgery and as a governor of the American College of Ophthalmic Surgery. Among the much deserved admiration and recognition for his contributions to medical science, he later became a member of the Overseers of the Geisel School of Medicine at Dartmouth College, where he endowed several research and scholarly funds. Former President Jimmy Carter appointed him to the National Health Resources Advisory Council in 1978, and later supported him for the Rank Prize for Opto Electioneers in 2010. Deerfield Academy also appointed him as a trustee and the recipient of its noted Heritage Award.

In ophthalmology, Fran was a retina specialist extraordinaire. His scientific advances benefited countless patients with diseases of the eye associated with severe vision loss. The development of ophthalmic lasers for the posterior segment of the eye provided therapeutic hope to patients with retinal vascular and choroidal-pigmentary epithelial diseases long before there was established treatment for such exudative chorioretinopathies. He also shared his knowledge and experience graciously and generously. I remember fondly, how he guided me through the photo optics of his original and innovative work on an Argon laser instrument assembled for him by Bell Labs. I witnessed this primitive Argon laser delivery system, escorted by a crane from a nearby group of construction workers, elevating it through the exterior at Harkness Eye Institute into his laboratory. It was too large to pass through the doors and corridors.

While others were using a new diagnostic adjunct, fluorescein angiography, to study disease mechanisms, Fran was focusing on the administration of laser light therapy with blue-green and eventually pure green laser to treat them. His early systems contained optical lenses and prisms which were converted to fiber optics in quest of a fine, short and intense nature to a focal spot in the posterior segment of the eye. He soon realized that such light of high energy had to be modified to reduce its potential complicating nature. He immediately realized that it was necessary to incorporate the concepts of other contemporary innovators like Drs. Gerhard Meyer-Schwickerath, Lloyd Aiello, and Arnal Patz to avoid potential complications like disruption of the pigment epithelial choroidal junction and predisposition to choroidal neovascularization or the fertilization of optic nerve preretinal neovascularization. With the emergence of clinical trials and imaging modalities, laser photocoagulation devices and techniques introduced by Fran, provided a sense of purpose for treating retinal physicians for permeability and proliferative vascular diseases. First and foremost was diabetic retinopathy followed soon after by retinal vascular occlusive diseases and eventually choroidal pigment epithelial ischemic and proliferative disorders. These photocoagulation therapeutic concepts catalyzed the medical-retinal studies on disease mechanisms which were now being managed with laser light photocoagulation based on Fran’s original research. This all occurred in an era that had not yet discovered the importance of anti-VEGF medication.  

Fran’s numerous publications, presentations, and organized meetings gradually introduced light coagulation as a method of treating these diseases and expanded the retinal base for studying them with new concepts in multimodal imaging. The New York State Ophthalmology Society, American Academy of Ophthalmology and International Council on Ophthalmology rapidly adopted fundamentals that were introduced by Fran and his laboratory associates. Retinal diagnostics now could be enhanced by retinal therapeutics, expanding the sphere of the retinal physician who was principally focused on detection and repair of retinal tears and detachments with cryo surgery and scleral buckling. So, thank you Fran, for doing your best to provide retinal specialists with laser forms of treatment, fundamentally, the only available method and reliable form of therapy prior to the advent of the anti-VEGF era.

Additional contribution by Aravindh Nirmalan, MD.

Read an additional tribute to Dr. L’Esperance in this Retina Times article: ASRS Remembers Francis A. L’Esperance Jr, MD.



Accepts position as clinical professor of ophthalmology at Columbia University College of Physicians and Surgeons

View PDF

Appointed by President Carter to the National Health Resources Advisory Council

View PDF

Co-founded Taunton Technologies for the advancement of laser eye surgery

View PDF

Merged Taunton Technologies with VISX. Inc

View PDF

Received Rank Prize for Optoelectronics

View PDF

Academic Appointment

1960 – 2007

  • Professor of Clinical Ophthalmology at Columbia University College of Physicians and Surgeons

Education & Training

Undergraduate Degree: Dartmouth College, 1953  

Medical Degree: Harvard Medical School, 1956

Surgical Internship: Columbia-Presbyterian Medical Center, 1957

Residency in Ophthalmology: Massachusetts Eye and Ear Infirmary, 1960


Hermann D. Schubert, MD

I first met Francis L’Esperance, MD, in the early 1980s as a resident assisting in Operating Room A of Columbia’s Edward S. Harkness Eye Institute. It was fairly dark there before the renovation but we had Emilie Bondoc, the ultimate nursing professional. I can still see him sitting at the head of the operating table, with the bulky indirect AO ophthalmoscope on his head looking down at a patient with a 20 diopter lens in his left hand and a vitrector and infusion sleeve in his right. “360 degree peritomy. Plenty of cautery.”

Dr. L’Esperance was always cordial and a gentleman exhibiting “refinement of manners” – rare today. His office was at One East 71st Street, in other words, 5th Avenue, a nice contrast to our clinic in the basement at 165th Street.

Dr. L’Esperance had an interest in ophthalmic lasers, as had Dr. Charles Campbell the subsequent chair. Dr. Campbell worked on the Ruby laser, assisted by American Optics and Dr. L’Esperance worked on the Argon laser, assisted by Bell Labs. Dr. L’Esperance had his laser lab on the 9th floor of the Institute and worked independent of Campbell’s group in Physiological Optics – a little friendly competition. In 1968, he wrote his AOS thesis on “An Ophthalmic Argon Laser Photocoagulation System,” and published extensively, including 10 textbooks and 23 patents.

In 1992, Dr. Anthony Donn and Dr. Steven Trokel decided to have a laser meeting in Paris, at the American Hospital in Neuilly. Dr. Trokel presented the Yag, Dr. L’Esperance presented the Argon and I presented the CW transscleral laser that I had studied in Philadelphia.


  1. New York Times. Obituaries. Feb 2022.
  2. Carole Moussalli. Laser Medicine and Surgery News and Advances. Jun 1989.21-24.